These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3709347)

  • 1. Influence of infusion methods on therapeutic drug monitoring in pediatric patients.
    Nahata MC
    Drug Intell Clin Pharm; 1986 May; 20(5):367-9. PubMed ID: 3709347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous flow rate and injection site on in vitro delivery of chloramphenicol succinate and in vivo kinetics.
    Nahata MC; Powell DA; Glazer JP; Hilty MD
    J Pediatr; 1981 Sep; 99(3):463-6. PubMed ID: 7264810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fitting methods for the analysis of plasma concentration-time data resulting from constant rate intravenous infusion.
    Johnson SL; Mayersohn M
    Biopharm Drug Dispos; 1985; 6(3):313-23. PubMed ID: 4041557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical studies on tobramycin by intravenous drip infusion (author's transl)].
    Toyonaga Y; Kurosu Y; Hori M
    Jpn J Antibiot; 1981 Nov; 34(11):1436-46. PubMed ID: 7334577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of infusion time on the time course of drug concentration in blood.
    Raymond K; Morgan DJ
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):573-82. PubMed ID: 7229909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous infusion conditions. Implications for pharmacokinetic monitoring.
    Nahata MC
    Clin Pharmacokinet; 1993 Mar; 24(3):221-9. PubMed ID: 8462228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of infusion regimens to achieve and maintain a predetermined plasma drug level range.
    Tsuei SE; Nation RL; Thomas J
    Clin Pharmacol Ther; 1980 Sep; 28(3):289-95. PubMed ID: 7408388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of intravenous infusion duration on the tissue drug concentration profile.
    Uccellini DA; Raymond K; Morgan DJ
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):323-34. PubMed ID: 3783449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic studies of tobramycin using the continuous intravenous infusion method (author's transl)].
    Yamasaku F; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1429-35. PubMed ID: 7334576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.
    Vaughan DP; Tucker GT
    Eur J Clin Pharmacol; 1976; 10(6):433-40. PubMed ID: 1001359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method for constant plasma drug concentrations: application to lidocaine.
    Riddell JG; McAllister CB; Wilkinson GR; Wood AJ; Roden DM
    Ann Intern Med; 1984 Jan; 100(1):25-8. PubMed ID: 6691655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consecutive intravenous infusions: simulation of two compartment pharmacokinetic drugs.
    Hieb BR; Shrewsbury B
    Comput Programs Biomed; 1980 Dec; 12(2-3):96-104. PubMed ID: 7249608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental and clinical studies on intravenous drip infusion of dibekacin in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Sakaguchi Y; Kimura K
    Jpn J Antibiot; 1985 Aug; 38(8):2068-86. PubMed ID: 4079001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a filter device used for intermittent intravenous drug delivery to newborn infants.
    Koren G; Rajchgot P; Harding E; Perlman M; MacLeod SM
    Am J Hosp Pharm; 1985 Jan; 42(1):106-8. PubMed ID: 3970024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring pediatric iv drugs.
    Smith SC; Crass RE
    Drug Intell Clin Pharm; 1984 Jun; 18(6):530-1. PubMed ID: 6734441
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic drug monitoring in neonates: problems and issues.
    Gal P
    Drug Intell Clin Pharm; 1988 Apr; 22(4):317-23. PubMed ID: 3286175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of pharmacokinetic parameters from postinfusion blood level data obtained after simultaneous administration of intravenous priming and infusion doses.
    Singhvi SM
    J Pharm Sci; 1977 Oct; 66(10):1499-501. PubMed ID: 925916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of infusion pump fill-stroke flow interruptions on simulated serum concentrations of short half-life drugs.
    Floyd RA
    Am J Hosp Pharm; 1984 Nov; 41(11):2399-400. PubMed ID: 6507446
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic problems arising from the use of the intravenous route for drug administration.
    Gould T; Roberts RJ
    J Pediatr; 1979 Sep; 95(3):465-71. PubMed ID: 469676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Pump Control Technology Accelerates Drug Delivery Onset in a Model of Pediatric Drug Infusion.
    Parker MJ; Lovich MA; Tsao AC; Deng H; Houle T; Peterfreund RA
    Anesth Analg; 2017 Apr; 124(4):1129-1134. PubMed ID: 28181934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.